PGY2 Pharmacy Residency in Thrombosis and Hemostasis Management
Program Need
Anticoagulants are the leading class of medications associated with emergency department visits for adverse events. The rapid expansion of approved anticoagulants, indications for their use, associated reversal strategies, and increasing overall prescribing makes safe and effective patient care increasingly complex and costly. Pharmacists play pivotal roles in thrombosis and hemostasis management and in the implementation and operation of successful multidisciplinary anticoagulation and hemostasis stewardship programs. Yet currently available residency programs do not fully prepare pharmacists for work in this dynamic and expanding field. This new ASHP-accredited PGY2 Residency in Thrombosis and Hemostasis Management will prepare pharmacists to practice in this rapidly evolving discipline and to cement the role of pharmacists in multidisciplinary anticoagulation stewardship programs.
Inaugural PGY2 Residency in Thrombosis and Hemostasis Management Initiated at the Brigham and Women’s Hospital
The Brigham & Women’s Hospital, Boston Massachusetts launched the nation's first PGY2 Residency in Thrombosis and Hemostasis Management in July 2022. This novel specialty residency program was formally approved by the ASHP Council on Credentialing (COC) in April 2022. The necessary framework on goals, objectives and structure have been finalized and were posted in PharmAcademic in Fall 2022 for programs interested in accessing this information.
Let’s hear from the first-in-nation THM resident resident!
Kristi Schwietz, Brigham and Women’s Hospital
Current Thrombosis & Hemostasis Management Residency Sites (as of July 2023)
Prospective candidates are encouraged to explore the links to each site and any additional resources provided:
- Brigham & Women’s Hospital, Boston, MA
- Froedtert & Medical College of Wisconsin,Milwaukee, WI*
- Henry Ford Hospital, Detroit MI*
- Hospital of the University of Pennsylvania (HUP), Philadelphia, PA*
- Intermountain Health , Murray, UT*
- Johns Hopkins Medicine, Baltimore MD*
- Medical University of South Carolina, Charleston, SC*
- Sanford University of South Dakota (USD) Medical Center, Sioux Falls SD*
- University of New Mexico, Albuquerque NM*
*Funded by Anticoagulation Forum’s TRAIN Grant
PGY2 Pharmacy Residency in Thrombosis and Hemostasis Management Learning Objectives
The PGY2 residency follows program competencies defined by ASHP. Please review them here: PGY2 Competency Areas.
New Residency Site Funding Opportunities
The Spring 2023 grant cycle has ended. Please check back regarding future opportunities.
About the Anticoagulation Forum
The Anticoagulation Forum (AC Forum) is a nonprofit organization dedicated to improving the quality of patient care by educating healthcare professionals and advocating for clinical best practices in the field of antithrombotic medications. Founded in 1991, the AC Forum is the largest organization of anticoagulation management specialists, made up of 14,000 physicians, pharmacists, and nurses representing over 3,000 anticoagulation practices and supporting over 1 million patients annually.